Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...

Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A ...

According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce infections significantly.

Florida will get $3 million as part of a nationwide settlement over allegations a drug manufacturer gave kickbacks to doctors.

Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a year and has demonstrated over 99.9% effectiveness in preventing HIV ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

The future of a nearly 100% effective, affordable HIV prevention drug reaching 115 nations largely depends on the speed of Indian drug regulators' approval process.